By Finance Pulse in MDCX —

Medicus Pharma Rated 'Buy' with $12 Target by Brookline

Brookline initiates coverage on Medicus Pharma (MDCX) with a Buy rating and $12 target, highlighting innovative skin patch technology.

An aesthetically appealing image of a futuristic translucent skin patch on a human arm, blending inn
Medicus Pharma Rated 'Buy' with $12 Target by Brookline

Brookline initiated coverage of Medicus Pharma with a Buy rating and $12 price target.

Source